|
2024
|
Invention
|
Base-modified cytidine nucleotides for leukemia therapy.
Compounds of the formula I
Compounds ... |
|
|
Invention
|
Method for treating liver cancers using fostroxacitabine bralpamide, an immune checkpoint inhibit... |
|
|
Invention
|
Treatment of lcpd with a cathepsin k inhibitor. The compound of the formula (I) (I) or a pharmace... |
|
2023
|
Invention
|
Purine derivatives as anticancer agents.
Compounds are provided according to Formula (I)
Compo... |
|
|
Invention
|
Dioxolane analogues of uridine for the treatment of cancer.
The invention provides compounds of ... |
|
|
Invention
|
Birinapant polymorph h. Provided herein is a specific crystalline form of the anti-cancer drug bi... |
|
|
Invention
|
Pharmaceutical formulation for histone deacetylase inhibitors.
A pharmaceutical composition, com... |
|
2022
|
Invention
|
Smac mimetic. A SMAC mimetic and pharmaceutical compositions thereof and methods of use. |
|
|
Invention
|
Protease inhibitors.
Compounds of the formula II:
Compounds of the formula II:
... |
|
|
Invention
|
Purine derivatives as anticancer agents. Compounds are provided according to Formula (I). Formula... |
|
2021
|
Invention
|
Malt1 modulators and uses thereof. Provided herein are compounds, compositions, and methods usefu... |
|
|
Invention
|
Miv-818/lenvatinib combination therapy for liver cancer.
Use of lenvatinib, or a pharmaceuticall... |
|
|
Invention
|
Miv-818/lenvatinib combination therapy for liver cancer. Use of lenvatinib, or a pharmaceutically... |
|
|
Invention
|
Malt1 inhibitors and uses thereof. The invention provides compounds of formula (I) wherein R1, R2... |
|
2020
|
Invention
|
Dioxolane analogues of uridine for the treatment of cancer. The invention provides compounds of t... |
|
|
Invention
|
Protease inhibitors. Compounds of the formula II:
or a pharmaceutically acceptable salt, N-oxid... |
|
|
Invention
|
Methods for treating liver cancers using an orally administered dioxolane nucleotide in combinati... |
|
2019
|
Invention
|
Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver canc... |
|
|
Invention
|
Base-modified cytidine nucleotides for leukemia therapy. 22, and pharmaceutically acceptable salt... |
|
|
Invention
|
Base-modified cytidine nucleotides for leukemia therapy. Compounds of the formula I wherein X is ... |
|
|
Invention
|
Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides.
The invention pr... |
|
|
Invention
|
Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides. The invention pro... |
|
2018
|
Invention
|
Hcv polymerase inhibitors.
The invention provides compounds of the formula:
The invention prov... |
|
|
Invention
|
Pyrazolopyrimidine as malt-1 inhibitors. The invention provides a compound of formula (I): herein... |
|
|
G/S
|
Pharmaceuticals. |
|
|
Invention
|
Therapeutic applications of malt1 inhibitors.
The present invention relates to novel application... |
|
|
Invention
|
Therapeutic applications of malt1 inhibitors. The present invention relates to novel applications... |
|
2017
|
Invention
|
Hcv polymerase inhibitors. The invention provides compounds of the formula:
wherein B is a nucl... |
|
|
Invention
|
Respiratory syncytial virus inhibitors. Compounds of Formula (I): wherein W is NR1A or CR1BR1B; Z... |
|
|
Invention
|
Protease inhibitors.
Compounds of the formula II:
Compounds of the formula II:
Compounds... |
|
|
Invention
|
Pharmaceutical formulation for histone deacetylase inhibitors. A pharmaceutical composition, comp... |
|
|
Invention
|
Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabine.... |
|
2016
|
Invention
|
Respiratory syncytial virus inhibitors.
Compounds of Formula (I): (Formula I), wherein Z1 is NR1... |
|
|
Invention
|
Nucleotide phosphoramidate formulation.
Compound 1 with the formula
Compound 1 with the formul... |
|
2013
|
G/S
|
Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic ... |
|
2010
|
G/S
|
Pharmaceutical preparations, namely, anti-inflammatory and
antiviral preparations for topical tr... |
|
|
G/S
|
Pharmaceutical preparations namely anti-inflammatory and
antiviral preparations for topical trea... |
